111 related articles for article (PubMed ID: 10968235)
1. Cutaneous malignant melanoma in children.
Vandeweyer E; Sales F; Deraemaecker R
Eur J Pediatr; 2000 Aug; 159(8):582-4. PubMed ID: 10968235
[TBL] [Abstract][Full Text] [Related]
2. Management of malignant melanoma.
Kroon BB; Nieweg OE
Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
[TBL] [Abstract][Full Text] [Related]
3. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
[TBL] [Abstract][Full Text] [Related]
4. [A case of adrenal gland metastasis of a cutaneous melanoma treated by excision with 3-year survival].
Claude R; Sale JM; Cavillon C; Rigondet G; Desplechain C; Egloff H; Franck F; Goujon N; Lautier A; Plagne R
Ann Urol (Paris); 1996; 30(1):44-5. PubMed ID: 8712760
[TBL] [Abstract][Full Text] [Related]
5. Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit?
Hofmann MA; Sterry W; Trefzer U
Jpn J Clin Oncol; 2007 Mar; 37(3):224-9. PubMed ID: 17472972
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy with dacarbazine, vindesine, and cisplatin in pathological stage II malignant melanoma.
Pectasides D; Alevizakos N; Bafaloukos D; Tzonou A; Asimakopoulos G; Varthalitis I; Dimitriadis M; Athanassiou A
Am J Clin Oncol; 1994 Feb; 17(1):55-9. PubMed ID: 8311008
[TBL] [Abstract][Full Text] [Related]
7. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
8. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma: a clinical review.
Brown TJ; Nelson BR
Cutis; 1999 May; 63(5):275-8, 281-4. PubMed ID: 10349543
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant chemotherapy in the combined treatment of primary circumscribed malignant melanoma of the skin].
Korovin SI
Lik Sprava; 1998 May; (3):114-7. PubMed ID: 9695586
[TBL] [Abstract][Full Text] [Related]
11. [Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas].
Aigner KR; Jungbluth A; Link KH; Walther H; Müller H; Schwemmle K; Ringenberg T; Börger G; Ruppel R; Illig L
Onkologie; 1984 Dec; 7(6):348-53. PubMed ID: 6396562
[TBL] [Abstract][Full Text] [Related]
12. Phase II randomized trial comparing high-dose IFN-α2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma.
Lian B; Si L; Cui C; Chi Z; Sheng X; Mao L; Li S; Kong Y; Tang B; Guo J
Clin Cancer Res; 2013 Aug; 19(16):4488-98. PubMed ID: 23833309
[TBL] [Abstract][Full Text] [Related]
13. Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
Jungnelius U; Ringborg U; Aamdal S; Mattsson J; Stierner U; Ingvar C; Malmström P; Andersson R; Karlsson M; Willman K; Wist E; Bjelkengren G; Westberg R
Eur J Cancer; 1998 Aug; 34(9):1368-74. PubMed ID: 9849419
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy in malignant melanoma using dacarbazine, carmustine, cisplatin, and tamoxifen: a University of South Florida and H. Lee Moffitt Melanoma Center Study.
Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS
Ann Plast Surg; 1992 Jan; 28(1):60-4. PubMed ID: 1642408
[TBL] [Abstract][Full Text] [Related]
15. Pediatric patients with cutaneous melanoma: A European study.
Brecht IB; De Paoli A; Bisogno G; Orbach D; Schneider DT; Leiter U; Offenmueller S; Cecchetto G; Godzinski J; Bien E; Stachowicz-Stencel T; Ben-Ami T; Chiaravalli S; Maurichi A; De Salvo GL; Sorbara S; Bodemer C; Garbe C; Reguerre Y; Ferrari A
Pediatr Blood Cancer; 2018 Jun; 65(6):e26974. PubMed ID: 29350487
[TBL] [Abstract][Full Text] [Related]
16. Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.
Robert C; Dummer R; Gutzmer R; Lorigan P; Kim KB; Nyakas M; Arance A; Liszkay G; Schadendorf D; Cantarini M; Spencer S; Middleton MR
Lancet Oncol; 2013 Jul; 14(8):733-40. PubMed ID: 23735514
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
Kudriavtsev DV; Kudriavtseva GT; Mardynskiĭ IuS
Vopr Onkol; 2008; 54(2):170-7. PubMed ID: 18522165
[TBL] [Abstract][Full Text] [Related]
18. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous melanoma: current practice and surgical controversies.
Mansfield PF; Lee JE; Balch CM
Curr Probl Surg; 1994 Apr; 31(4):253-374. PubMed ID: 8143489
[No Abstract] [Full Text] [Related]
20. Liver resection in multimodal concepts improves survival of metastatic melanoma: a single-centre case-matched control study.
Hau HM; Tautenhahn HM; Schoenberg MB; Atanasov G; Wiltberger G; Morgül MH; Uhlmann D; Seitz AT; Simon JC; Schmelzle M; Bartels M
Anticancer Res; 2014 Nov; 34(11):6633-9. PubMed ID: 25368268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
